Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High vs Low Dose Corticosteroid in Severe Lung Contusion With ARDS
NCT04467892Phase 2Completed
- Sponsor
- King Abdulaziz Specialist Hospital
- Start
- Jan 2018
- Primary completion
- Feb 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone injection in ventilator-associated pneumonia (VAP), acute respiratory distress syndrome (ARDS), Lung Contusion, sponsored by King Abdulaziz Specialist Hospital. Started Jan 2018; status: completed.
02
Drugs
methylprednisolone injection
03
Conditions
ventilator-associated pneumonia (VAP)acute respiratory distress syndrome (ARDS)Lung Contusion
Beyond the preview
Go deeper on NCT04467892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467892.